Q1 Earnings Hit by $425M Greensill Litigation Charge Despite Revenue Growth

summarizeSummary

Marsh & McLennan reported Q1 2026 revenue growth, but a $425 million charge from the Greensill litigation caused a 12% drop in operating income and a 15% decline in diluted EPS.

check_boxKey Events

• Q1 2026 Financial Performance

  Consolidated revenue increased 8% (4% on an underlying basis) to $7.6 billion. However, operating income decreased 12% to $1.8 billion, and diluted EPS fell 15% to $2.36, compared to the prior year period.

• Significant Greensill Litigation Charge

  The company recorded a $425 million gross liability and legal expenses in Q1 2026 related to the ongoing Greensill litigation in Australia, which was the primary driver for the decline in profitability.

• Share Repurchase Activity

  Marsh & McLennan repurchased $750 million of its common stock in Q1 2026, with approximately $4.9 billion remaining under the existing authorization, continuing its capital return program.

• Debt Management

  The company issued $600 million in 4.950% senior notes due 2036 and repaid $600 million in 3.750% senior notes at maturity, actively managing its debt portfolio.

auto_awesomeAnalysis

Marsh & McLennan's first-quarter results show solid underlying revenue growth, but profitability was significantly impacted by a substantial $425 million charge related to the Greensill litigation. This legal liability led to a double-digit decline in operating income and diluted EPS, overshadowing the positive top-line performance. Investors should monitor the ongoing litigation's future impact and the progress of the 'Thrive' restructuring program, which is incurring costs while aiming for efficiency gains.